Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19.
Functional status
Quality of life
SARS-CoV-2
Symptoms
Journal
Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626
Informations de publication
Date de publication:
03 Feb 2021
03 Feb 2021
Historique:
received:
26
11
2020
accepted:
26
01
2021
entrez:
4
2
2021
pubmed:
5
2
2021
medline:
13
2
2021
Statut:
epublish
Résumé
An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire. We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19.
METHODS
METHODS
Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale.
RESULTS
RESULTS
1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing 'slight', 'moderate' and 'severe' functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing 'negligible' and 'no' functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233-0.661). Notably, the strongest association found was with the 'usual activities' domain of the 5-level EQ-5D questionnaire.
CONCLUSION
CONCLUSIONS
We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.
Identifiants
pubmed: 33536042
doi: 10.1186/s12955-021-01691-2
pii: 10.1186/s12955-021-01691-2
pmc: PMC7856622
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Références
Arch Intern Med. 2007 Jun 25;167(12):1312-20
pubmed: 17592106
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
PLoS One. 2019 Feb 4;14(2):e0211532
pubmed: 30716129
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Pharmacoeconomics. 2016 Dec;34(12):1277-1297
pubmed: 27581788
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
Value Health. 2016 Jun;19(4):343-52
pubmed: 27325326
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Qual Life Res. 2006 Feb;15(1):83-91
pubmed: 16411033
Thromb Res. 2020 Jun;190:45-51
pubmed: 32298840
J Clin Med. 2020 Sep 12;9(9):
pubmed: 32932582
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
J Clin Med. 2020 Dec 09;9(12):
pubmed: 33317214
Thromb Res. 2020 Jul;191:148-150
pubmed: 32381264
J Palliat Med. 2011 Mar;14(3):337-42
pubmed: 21254813
Eur Respir J. 2020 Jul 2;56(1):
pubmed: 32398306
Thorax. 2005 May;60(5):401-9
pubmed: 15860716
Thromb Res. 2019 Jun;178:59-62
pubmed: 30980999
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
Health Qual Life Outcomes. 2004 Sep 20;2:51
pubmed: 15380021